Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases. (22nd March 2021)
- Record Type:
- Journal Article
- Title:
- Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases. (22nd March 2021)
- Main Title:
- Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
- Authors:
- Giacobino, Davide
Camerino, Mariateresa
Riccardo, Federica
Cavallo, Federica
Tarone, Lidia
Martano, Marina
Dentini, Alfredo
Iussich, Selina
Lardone, Elena
Franci, Paolo
Valazza, Alberto
Manassero, Luca
Del Magno, Sara
De Maria, Raffaella
Morello, Emanuela
Buracco, Paolo - Other Names:
- Selmic Laura guestEditor.
Culp William guestEditor. - Abstract:
- Abstract: Canine oral malignant melanoma is locally invasive and highly metastatic. At present, the best option for local control is en bloc excision followed by radiation if excision margins are incomplete. Adjuvantly, the role of chemotherapy is dubious while immunotherapy appears encouraging. This retrospective study evaluated 155 dogs with oral malignant melanomas (24 stage I, 54 stage II, 66 stage III and 11 stage IV) managed in a single institution. The aim was to evaluate the differences in median survival time (MST) and disease‐free interval (DFI) between dogs which, at presentation, were treated surgically with a curative intent (group 1) vs those marginally excised only (group 2). MST in group 1 was longer than in group 2 (594 vs 458 days), but no significant difference was found ( P = .57); a statistical difference was, however, found for DFI (232 vs 183 days, P = .008). In the subpopulation of vaccinated dogs, the impact of adjuvant anti‐CSPG4 DNA electrovaccination was then evaluated (curative intent, group 3, vs marginal, group 4); a significant difference for both MST (1333 vs 470 days, respectively, P = .03) and DFI (324 vs 184 days, respectively, P = .008) was found. Progressive disease was significantly more common in dogs undergoing marginal excision than curative intent excision for both the overall population ( P = .03) and the vaccinated dogs ( P = .02). This study pointed out that, after staging, wide excision together with adjuvant immunotherapyAbstract: Canine oral malignant melanoma is locally invasive and highly metastatic. At present, the best option for local control is en bloc excision followed by radiation if excision margins are incomplete. Adjuvantly, the role of chemotherapy is dubious while immunotherapy appears encouraging. This retrospective study evaluated 155 dogs with oral malignant melanomas (24 stage I, 54 stage II, 66 stage III and 11 stage IV) managed in a single institution. The aim was to evaluate the differences in median survival time (MST) and disease‐free interval (DFI) between dogs which, at presentation, were treated surgically with a curative intent (group 1) vs those marginally excised only (group 2). MST in group 1 was longer than in group 2 (594 vs 458 days), but no significant difference was found ( P = .57); a statistical difference was, however, found for DFI (232 vs 183 days, P = .008). In the subpopulation of vaccinated dogs, the impact of adjuvant anti‐CSPG4 DNA electrovaccination was then evaluated (curative intent, group 3, vs marginal, group 4); a significant difference for both MST (1333 vs 470 days, respectively, P = .03) and DFI (324 vs 184 days, respectively, P = .008) was found. Progressive disease was significantly more common in dogs undergoing marginal excision than curative intent excision for both the overall population ( P = .03) and the vaccinated dogs ( P = .02). This study pointed out that, after staging, wide excision together with adjuvant immunotherapy was an effective approach for canine oral malignant melanoma. … (more)
- Is Part Of:
- Veterinary and comparative oncology. Volume 19:Number 4(2021)
- Journal:
- Veterinary and comparative oncology
- Issue:
- Volume 19:Number 4(2021)
- Issue Display:
- Volume 19, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 19
- Issue:
- 4
- Issue Sort Value:
- 2021-0019-0004-0000
- Page Start:
- 651
- Page End:
- 660
- Publication Date:
- 2021-03-22
- Subjects:
- adjuvant immunotherapy -- CSPG4 -- DNA electrovaccination -- dog -- oral malignant melanoma -- surgery
Veterinary oncology -- Periodicals
Neoplasms -- veterinary -- Periodicals
636.0896994005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1476-5810;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5829 ↗
http://www.blackwell-synergy.com/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/vco.12690 ↗
- Languages:
- English
- ISSNs:
- 1476-5810
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9226.528800
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20002.xml